论文部分内容阅读
目的探讨阿托伐他汀+曲美他嗪共同治疗冠心病的效果评价。方法选取该院2015年5月—2016年5月收治的冠心病患者122名。按照入院的先后顺序,分为对照组和观察组。其中对照组使用曲美他嗪片进行治疗,观察组使用阿托伐他汀和曲美他嗪两种药物同时口服进行治疗。通过对二组患者进行治疗前后的血脂指标进行检测,同时进行疗效对比。结果二组患者经过治疗前后的总胆固醇参数、三酰甘油参数、低密度和高密度脂蛋白参数统计,对患者疗效进行对比。观察组的各项指标均优于对照组,具有统计学意义(P<0.05)。结论阿托伐他汀+曲美他嗪联合治疗能有效降低冠心病的发病率,此药物治疗方法值得在临床上广泛进行推广。
Objective To investigate the efficacy of atorvastatin combined with trimetazidine in the treatment of coronary heart disease. Methods 122 patients with coronary heart disease admitted to our hospital from May 2015 to May 2016 were selected. In accordance with the order of admission, divided into control group and observation group. The control group was treated with trimetazidine. The observation group was treated with both atorvastatin and trimetazidine orally. Through the two groups of patients before and after treatment of blood lipids were detected, while the efficacy comparison. Results The total cholesterol parameters, triglyceride parameters, low density and high density lipoprotein parameters before and after treatment in two groups were compared, and the therapeutic effect was compared. The indicators of the observation group were better than the control group, with statistical significance (P <0.05). Conclusions Atorvastatin combined with trimetazidine can effectively reduce the incidence of coronary heart disease. The drug treatment should be widely applied clinically.